Stock Taper 
NRXP
$3.49
▲ UP 1.75% (0.06)
KEY STATISTICS
Market Cap$59.72 M
52w High$5.05
52w Low$1.62
Dividend Yield—
Frequency—
P/E-9.43
Volume479.89K
Shares Out.17.29M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Jonathan C. Javitt
COMPENSATION 2026
Salary$575,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$825,000
ABOUT
SECTOR
Healthcare
WENT PUBLIC
December 4, 2017
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
29
PRICE TARGET
Target High$2.00
Target Low$2.00
Target Median$2.00
Target Consensus$2.00
UPCOMING EARNINGS
DateNov 13, 2026
DayFriday
Rev. Est.$1.33M
NOV
13
FRI
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2024-04-02 | Reverse | 1:10 |
PRICE
$3.49 ▲ UP 1.75% (+$0.06)About NRx Pharmaceuticals, Inc.
https://www.nrxpharma.com ↗NRX Pharmaceuticals, founded in 2015 in Wilmington, Delaware, is a clinical-stage company developing novel therapeutics for CNS disorders and pulmonary diseases, including ZYESAMI for COVID-19 respiratory failure and NRX-100/101 for bipolar depres...
INDUSTRY
Biotechnology
A PRODUCT NRX PHARMACEUTICALS, INC. IS KNOWN FOR
NRX-100 (preservative-free ketamine)
NRX-100 is an FDA-guided intravenous ketamine formulation for suicidal depression, currently the company's top priority for New Drug Application development.
Revenue by Products
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | Therapy | $152K | $702K ▲ | $760K ▲ | $871K ▲ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
13
LISTED HERE
3
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
50.26%
HOLDERS
45
TOP 12 OF 45 · RANKED BY POSITION SIZE
Anson Funds Management LP
B Group, Inc.
Vanguard Group Inc
Advisorshares Investments LLC
Commonwealth Equity Services, LLC
Geode Capital Management, LLC
Marshall Wace, Llp
Ubs Group AG
Renaissance Technologies LLC
Bleakley Financial Group, LLC
Vertex One Asset Management Inc.
Blackrock, Inc.
RATINGS SNAPSHOT
Overall rating: C+
Discounted Cash Flow3
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2
INSIDER TRADES
★
OFFICER: CHIEF OPERATING OFFICER
Casper Joseph Michael
Purchase · 100.0K shares
2026-01-27
★
OFFICER: CHIEF OPERATING OFFICER
Casper Joseph Michael
— · 100.0K shares
2026-01-27
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHAIRMAN AND CHIEF SCIENTIST
Javitt Jonathan C
Purchase · 125.0K shares
2025-04-09
★
DIRECTOR
McBride Dennis
Purchase · 25.0K shares
2025-04-09
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 4
4 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 IPSC | $2.14 | COMPARE |
 SPRB | $57.49 | COMPARE |
 EQ | $2.25 | COMPARE |
 OTLK | $0.67 | COMPARE |
 CUE | $27.43 | COMPARE |
 HOWL | $0.95 | COMPARE |
 KPTI | $1.81 | COMPARE |
 SNTI | $0.33 | COMPARE |